skip to main content
Show Results with:

Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn'’s disease in children: REACH open-label extension

Hyams, J. et al.

Current medical research and opinion. VOL 27; NUMBER 3, ; 2011, 651-662 -- Informa Healthcare -- 2011

Online access

Notes here allow you and other users to comment and make notes on items, viewable by the whole community.
NB: Please use the Report Catalogue Error form to advise us of catalogue inaccuracies.

Log in to add a note

Tags allow you and others to define and search on related groups of items.

Log in to add / remove tags

Searching Remote Databases, Please Wait